Salmonella infections in immunocompromised adults

Journal of Infection

Volumn 56, Issue 6, 2008, Pages 413-422

  Gordon, Melita A ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

Author keywords

Adults; Africa; AIDS; Antibiotic resistance; Cytokines; HIV; Immunosuppression; Nontyphoidal salmonella; Salmonella; Salmonella Typhi; Typhoid

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN 23P19; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BLOOD CULTURE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL TRIAL; CROHN DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; EPIDEMIC; FATALITY; HIGH RISK POPULATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION RISK; INFECTIOUS DIARRHEA; MORTALITY; NONHUMAN; PATHOGENESIS; REVIEW; RISK FACTOR; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SALMONELLOSIS; SCHISTOSOMIASIS; TYPHOID FEVER; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; SALMONELLA INFECTIONS;

EID: 44649113673     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.03.012     Document Type: Review

References (87)

1. Graham S.M. Salmonellosis in children in developing and developed countries and populations. Curr Opin Infect Dis 15 5 (2002) 507-512
2. Graham S.M., Molyneux E.M., Walsh A.L., Cheesbrough J.S., Molyneux M.E., and Hart C.A. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J 19 12 (2000) 1189-1196
3. Hornick R.B., Greisman S.E., Woodward T.E., DuPont H.L., Dawkins A.T., and Snyder M.J. Typhoid fever: pathogenesis and immunologic control. N Engl J Med 283 13 (1970) 686-691
4. Wain J., Pham V.B., Ha V., Nguyen N.M., To S.D., Walsh A.L., et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol 39 4 (2001) 1571-1576
5. Parry C.M., Hien T.T., Dougan G., White N.J., and Farrar J.J. Typhoid fever. N Engl J Med 347 22 (2002) 1770-1782
6. Bhan M.K., Bahl R., and Bhatnagar S. Typhoid and paratyphoid fever. Lancet 366 9487 (2005) 749-762
7. Gilman R.H., Islam S., Rabbani H., and Ghosh H. Identification of gallbladder typhoid carriers by a string device. Lancet 1 8120 (1979) 795-796
8. Caygill C.P., Hill M.J., Braddick M., and Sharp J.C. Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 343 8889 (1994) 83-84
9. Dunstan S.J., Hue N.T., Rockett K., Forton J., Morris A.P., Diakite M., et al. A TNF region haplotype offers protection from typhoid fever in Vietnamese patients. Hum Genet 122 1 (2007) 51-61
10. Gotuzzo E., Frisancho O., Sanchez J., Liendo G., Carrillo C., Black R.E., et al. Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med 151 2 (1991) 381-382
11. Khan M., Coovadia Y., and Sturm A.W. Typhoid fever and asymptomatic human immunodeficiency virus infection. A report of 10 cases. J Clin Gastroenterol 25 3 (1997) 507-512
12. Chierakul W., Rajanuwong A., Wuthiekanun V., Teerawattanasook N., Gasiprong M., Simpson A., et al. The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans R Soc Trop Med Hyg 98 11 (2004) 678-686
13. Gilks C.F., Brindle R.J., Otieno L.S., Simani P.M., Newnham R.S., Bhatt S.M., et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 336 8714 (1990) 545-549
14. Vugia D.J., Kiehlbauch J.A., Yeboue K., N'Gbichi J.M., Lacina D., Maran M., et al. Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, West Africa. J Infect Dis 168 3 (1993) 564-570
15. Peters R.P.H., Zijlstra E.E., Schijffelen M.J., Walsh A.L., Joaki G., Kumwenda J.J., et al. A prospective study of bloodstream infections as a cause of fever in Malawi - clinical predictors and implications for management. Trop Med Int Health 9 8 (2004) 928-934
16. Gordon M.A., Graham S.M., Walsh A.L., Wilson L., Phiri A., Molyneux E., et al. Epidemics of Invasive Salmonella enteritidis serovar Enteritidis and S. Typhimurium Infections among Adults and Children, associated with Multidrug Resistance in Malawi. Clin Infect Dis 46 (2008) 963-969
17. Boyd J.F. Pathology of the alimentary tract in Salmonella typhimurium food poisoning. Gut 26 9 (1985) 935-944
18. Giannella R.A., Broitman S.A., and Zamcheck N. Salmonella enteritis I. Role of reduced gastric secretion in pathogenesis. Am J Dig Dis 16 11 (1971) 1000-1006
19. Kunz L.J., and Waddell W.R. Association of Salmonella enteritis with operations on the stomach. N Engl J Med 255 12 (1956) 555-559
20. Leonard J., Marshall J.K., and Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 102 9 (2007) 2047-2056
21. Delarocque-Astagneau E., Bouillant C., Vaillant V., Bouvet P., Grimont P.A., and Desenclos J.C. Risk factors for the occurrence of sporadic Salmonella enterica serotype typhimurium infections in children in France: a national case-control study. Clin Infect Dis 31 2 (2000) 488-492
22. Galofre J., Moreno A., Mensa J., Miro J.M., Gatell J.M., Almela M., et al. Analysis of factors influencing the outcome and development of septic matastasis or relapse in salmonella bacteraemia. Clin Infect Dis 18 (1994) 873-878
23. Chen P.L., Chang C.M., Wu C.J., Ko N.Y., Lee N.Y., Lee H.C., et al. Extraintestinal focal infections in adults with nontyphoid salmonella bacteraemia: predisposing factors and clinical outcome. J Intern Med 261 1 (2007) 91-100
24. Cohen J.I., Bartlett J.A., and Corey G.R. Extra-intestinal manifestations of Salmonella infections. Medicine (Baltimore) 66 (1987) 349-388
25. Ramos J.M., Garcia-Corbeira P., Aguado J.M., Ales J.M., and Soriano F. Classifying extraintestinal non-typhoid Salmonella infections. QJM 89 2 (1996) 123-126
26. Tai T.Y., Hsu C.Y., Chang H.C., and Liu Y.K. Typhoid and paratyphoid fevers occurring in cases of schistosomiasis. Chin Med J (Engl) 76 (1958) 426-435
27. Neves J., Marinho R.P., Martins N.R., and de Araujo P.K. Prolonged septicaemic salmonellosis: treatment of intercurrent schistosomiasis with niridazole. Trans R Soc Trop Med Hyg 63 1 (1969) 79-84
28. Gendrel D., Kombila M., Beaudoin-Leblevec G., and Richard-Lenoble D. Nontyphoidal salmonellal septicemia in Gabonese children infected with Schistosoma intercalatum. Clin Infect Dis 18 1 (1994) 103-105
29. Melhem R.F., and LoVerde P.T. Mechanism of interaction of Salmonella and Schistosoma species. Infect Immun 44 (1984) 274-281
30. Han T., Sokal J.E., and Neter E. Salmonellosis in disseminated malignant diseases. A seven-year review (1959-1965). N Engl J Med 276 19 (1967) 1045-1052
31. Abramson S., Kramer S.B., Radin A., and Holzman R. Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital. Arthritis Rheum 28 1 (1985) 75-79
32. Samra Y., Shaked Y., and Maier M.K. Nontyphoid salmonellosis in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 8 3 (1986) 431-440
33. Pablos J.L., Aragon A., and Gomez-Reino J.J. Salmonellosis and systemic lupus erythematosus. Report of ten cases. Br J Rheumatol 33 2 (1994) 129-132
34. Cherubin C.E., Neu H.C., Imperato P.J., Harvey R.P., and Bellen N. Septicemia with non-typhoid salmonella. Medicine (Baltimore) 53 5 (1974) 365-376
35. Brown M., and Eykyn S.J. Non-typhoidal salmonella bacteraemia without gastroenteritis: a marker of underlying immunosuppression. Review of cases at St. Thomas' hospital 1970-1999. J Infect 41 3 (2000) 256-259
36. Ramos J.M., Garcia-Corbeira P., Aguado J.M., Arjona R., Ales J.M., and Soriano F. Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 19 4 (1994) 777-780
37. Winkelstein J.A., Marino M.C., Johnston Jr. R.B., Boyle J., Curnutte J., Gallin J.I., et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79 3 (2000) 155-169
38. Burniat W., Toppet M., and de Mol P. Acute and recurrent Salmonella infections in three children with chronic granulomatous disease. J Infect 2 3 (1980) 263-268
39. Safe A.F., Maxwell R.T., Howard A.J., and Garcia R.C. Relapsing Salmonella enteritidis infection in a young adult male with chronic granulomatous disease. Postgrad Med J 67 784 (1991) 198-201
40. Liese J., Kloos S., Jendrossek V., Petropoulou T., Wintergerst U., Notheis G., et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137 5 (2000) 687-693
41. Mabey D.C., Brown A., and Greenwood B.M. Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis 155 6 (1987) 1319-1321
42. Graham S.M., Walsh A.L., Molyneux E.M., Phiri A.J., and Molyneux M.E. Clinical presentation of non-typhoidal salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg 94 3 (2000) 310-314
43. Bronzan R.N., Taylor T.E., Mwenechanya J., Tembo M., Kayira K., Bwanaisa L., et al. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis 195 6 (2007) 895-904
44. Brent A.J., Oundo J.O., Mwangi I., Ochola L., Lowe B., and Berkley J.A. Salmonella bacteremia in Kenyan children. Pediatr Infect Dis J 25 3 (2006) 230-236
45. Mastroeni P., Harrison J.A., Robinson J.H., Clare S., Khan S., Maskell D.J., et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 66 10 (1998) 4767-4776
46. Monack D.M., Bouley D.M., and Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFN gamma neutralization. J Exp Med 199 2 (2004) 231-241
47. van de Vosse E., and Ottenhoff T.H. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect 8 4 (2006) 1167-1173
48. MacLennan C., Fieschi C., Lammas D.A., Picard C., Dorman S.E., Sanal O., et al. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 190 10 (2004) 1755-1757
49. Brenchley J.M., and Douek D.C. HIV infection and the gastrointestinal immune system. Mucosal Immunol 1 (2008) 23-30
50. Mannon P.J., Fuss I.J., Mayer L., Elson C.O., Sandborn W.J., Present D., et al. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351 20 (2004) 2069-2079
51. Krueger G.G., Langley R.G., Leonardi C., Yeilding N., Guzzo C., Wang Y., et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356 6 (2007) 580-592
52. Bongartz T., Sutton A.J., Sweeting M.J., Buchan I., Matteson E.L., and Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295 19 (2006) 2275-2285
53. Dixon W.G., Watson K., Lunt M., Hyrich K.L., Silman A.J., and Symmons D.P. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54 8 (2006) 2368-2376
54. Symmons D.P., and Silman A.J. The world of biologics. Lupus 15 3 (2006) 122-126
55. Mastroeni P., Villarreal-Ramos B., and Hormaeche C.E. Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model. Microb Pathog 14 6 (1993) 473-480
56. Fu A., Bertouch J.V., and McNeil H.P. Disseminated Salmonella typhimurium infection secondary to infliximab treatment. Arthritis Rheum 50 9 (2004) 3049
57. Katsarolis I., Tsiodras S., Panagopoulos P., Giannitsioti E., Skarantavos G., Ioannidis T., et al. Septic arthritis due to Salmonella enteritidis associated with infliximab use. Scand J Infect Dis 37 4 (2005) 304-305
58. Makkuni D., Kent R., Watts R., and Clunie G. Two cases of serious food-borne infection in patients treated with anti-TNF-alpha. Are we doing enough to reduce the risk?. Rheumatology (Oxford) 45 2 (2006) 237-238
59. Netea M.G., Radstake T., Joosten L.A., Van der Meer J.W., Barrera P., and Kullberg B.J. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and toll-like receptor 4 expression. Arthritis Rheum 48 7 (2003) 1853-1857
60. Clumeck N., Mascart-Lemone F., de Maubeuge J., Brenez D., and Marcelis L. Acquired immune deficiency syndrome in Black Africans. Lancet 1 8325 (1983) 642
61. Offenstadt G., Pinta P., Hericord P., Jagueux M., Jean F., Amstutz P., et al. Multiple opportunistic infection due to AIDS in a previously healthy black woman from Zaire. N Engl J Med 308 13 (1983) 775
62. Pitchenik A.E., Fischl M.A., Dickinson G.M., Becker D.M., Fournier A.M., O'Connell M.T., et al. Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med 98 3 (1983) 277-284
63. Piot P., Quinn T.C., Taelman H., Feinsod F.M., Minlangu K.B., Wobin O., et al. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 2 8394 (1984) 65-69
64. Van de Perre P., Rouvroy D., Lepage P., Bogaerts J., Kestelyn P., Kayihigi J., et al. Acquired immunodeficiency syndrome in Rwanda. Lancet 2 8394 (1984) 62-65
65. Bottone E.J., Wormser G.P., and Duncanson F.P. Nontyphoidal Salmonella bacteremia as an early infection in acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 2 3 (1984) 247-250
66. Profeta S., Forrester C., Eng R.H., Liu R., Johnson E., Palinkas R., et al. Salmonella infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 145 4 (1985) 670-672
67. Gruenewald R., Blum S., and Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infect Dis 18 3 (1994) 358-363
68. Levine W.C., Buehler J.W., Bean N.H., and Tauxe R.V. Epidemiology of nontyphoidal salmonella bacteremia during the human immunodeficiency virus epidemic. J Infect Dis 164 1 (1991) 81-87
69. Archibald L.K., den Dulk M.O., Pallangyo K.J., and Reller L.B. Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis 26 2 (1998) 290-296
70. Ssali F.N., Kamya M.R., Wabwire-Mangen F., Kasasa S., Joloba M., Williams D., et al. A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol 19 5 (1998) 484-489
71. Bell M., Archibald L.K., Nwanyanwu O., Dobbie H., Tokars J., Kazembe P.N., et al. Seasonal variation in the etiology of bloodstream infections in a febrile inpatient population in a developing country. Int J Infect Dis 5 2 (2001) 63-69
72. Kassa-Kelembho E., Mbolidi C.D., Service Y.B., Morvan J., and Minssart P. Bacteremia in adults admitted to the Department of Medicine of Bangui Community Hospital (Central African Republic). Acta Trop 89 1 (2003) 67-72
73. Archibald L.K., McDonald L.C., Rheanpumikankit S., Tansuphaswadikul S., Chaovanich A., Eampokalap B., et al. Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/= 15 years old, Bangkok. J Infect Dis 180 1 (1999) 87-92
74. Gordon M.A., Banda H.T., Gondwe M., Gordon S.B., Boeree M.J., Walsh A.L., et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16 1633 (2002) 1641
75. Gordon M.A., Gordon S.B., Musaya L., Zijlstra E.E., Molyneux M.E., and Read R.C. Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing. AIDS 21 18 (2007) 2399-2408
76. Gordon M.A., Walsh A.L., Chaponda M., Soko D., Mbvwinji M., Molyneux M.E., et al. Bacteraemia and mortality among adult medical admissions in Malawi - predominance of non-typhi salmonellae and Streptococcus pneumoniae. J Infect 42 1 (2001) 44-49
77. Thamlikitkul V., Dhiraputra C., Paisarnsinsup T., and Chareandee C. Non-typhoidal salmonella bacteraemia: clinical features and risk factors. Trop Med Int Health 1 4 (1996) 443-448
78. Arthur G., Nduba V.N., Kariuki S.M., Kimari J., Bhatt S.M., and Gilks C.F. Trends in bloodstream Infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. Clin Infect Dis 33 2 (2001) 248-256
79. Casado J.L., Navas E., Frutos B., Moreno A., Martin P., Hermida J.M., et al. Salmonella lung involvement in patients with HIV infection. Chest 112 5 (1997) 1197-1201
80. Satue J.A., Aguado J.M., Ramon C.J., Robledo M., De Miguel E., Hernandez J., et al. Pulmonary abscess due to non-typhi Salmonella in a patient with AIDS. Clin Infect Dis 19 3 (1994) 555-557
81. Ankobiah W.A., and Salehi F. Salmonella lung abscess in a patient with acquired immunodeficiency syndrome. Chest 100 2 (1991) 591
82. Albrecht H., Stellbrink H.J., Fenske S., Steiner P., and Greten H. Salmonella typhimurium lung abscesses in an HIV-infected patient: successful treatment with oral ciprofloxacin. AIDS 6 11 (1992) 1400-1401
83. Jacobs J.L., Gold J.W., Murray H.W., Roberts R.B., and Armstrong D. Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 102 2 (1985) 186-188
84. Thyrault M., Gachot B., and Wolff M. Acute non-lithiasic cholecystitis caused by Salmonella enteritidis in AIDS. Presse Med 22 16 (1993) 785
85. Kariuki S., Revathi G., Kariuki N., Kiiru J., Mwituria J., Muyodi J., et al. Invasive multidrug-resistant non-typhoidal Salmonella infections in Africa: zoonotic or anthroponotic transmission?. J Med Microbiol 55 Pt 5 (2006) 585-591
86. Sirinavin S., and Garner P. Antibiotics for treating salmonella gut infections. Cochrane Database Syst Rev 2 (2000) CD001167
87. Raffatellu M., Santos R.L., Verhoeven D., Wilson R.P., Winter S.E., Godinez I., et al. Simian immunodeficiency virus-induced mucosal IL-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14 (2008) 421-428